Related Reading
- 2025-09-22
FDA grants accelerated approval to Elamipretide
- 2025-04-09
Trump’s Tariff Triggered Turmoil: The Economic & Market Fallout
- 2025-01-16
Rep. Gottheimer Makes Waves with $40M in Microsoft Stock Options
- 2024-08-06
Lilly and Novo Nordisk Compete for Weight-Loss Market Dominance
- 2024-05-28
Lawmakers Trade Shares Amid Surging Demand for Weight-Loss Drugs
- 2024-05-10
Rep. Khanna's April investments: In $DHR, $ABT, $BIIB; Out $GM, $MU, $LLY